Mualliflar

  • Idiev G'.E., Babayeva N.M.

##semicolon##

leykoplakiyа, og‘iz bo‘shlig‘i mikrobiotasi, lisozim, immunoglobulin A, ozonoterapiya, fotodinamik terapiya.

##submission.citations##

World Health Organization. Oral Health Surveys: Basic Methods. WHO, 2013.

Warnakulasuriya S. et al. Oral potentially malignant disorders: a consensus report. Oral Diseases, 2021;27(3): 736–752.

Gupta N. et al. Global epidemiology of oral leukoplakia. Oral Oncology, 2016;62: 70–81.

Хакимов Ф.Ш., Абдуллаев Р.К. Эпидемиология и клинические особенности лейкоплакии слизистой оболочки полости рта в Узбекистане. Стоматология, 2020;99(2): 45–49.

Petti S. Lifestyle risk factors for oral cancer. Oral Oncology, 2009;45(4-5): 340–350.

Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol, 2005;32: S59–S66.

Kumar A. et al. Role of oxidative stress in oral diseases. J Oral Maxillofac Pathol, 2013;17(1): 6–15.

van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncology, 2009;45(4-5): 317–323.

Arduino P.G. et al. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients. Med Oral Patol Oral Cir Bucal, 2009;14(9): E461–E466.

Lodi G., Porter S. Management of potentially malignant disorders: evidence and critique. J Oral Pathol Med, 2008;37(2): 63–69.